• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081245)   Today's Articles (85)
For: Baker BF, Monia BP. Novel mechanisms for antisense-mediated regulation of gene expression. Biochim Biophys Acta 1999;1489:3-18. [PMID: 10806993 DOI: 10.1016/s0167-4781(99)00146-3] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Number Cited by Other Article(s)
51
Donaldson SF, Bergmeier SC, Hines JV, Gerdeman MS. Synthesis and hybridization studies of a 5-aminopentanoic acid nucleobase (APN) dimer. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS 2002;21:111-23. [PMID: 11991139 DOI: 10.1081/ncn-120003176] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
52
Aartsma-Rus A, Bremmer-Bout M, Janson AAM, den Dunnen JT, van Ommen GJB, van Deutekom JCT. Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul Disord 2002;12 Suppl 1:S71-7. [PMID: 12206800 DOI: 10.1016/s0960-8966(02)00086-x] [Citation(s) in RCA: 134] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
53
Yacyshyn BR, Barish C, Goff J, Dalke D, Gaspari M, Yu R, Tami J, Dorr FA, Sewell KL. Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease. Aliment Pharmacol Ther 2002;16:1761-70. [PMID: 12269969 DOI: 10.1046/j.1365-2036.2002.01341.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
54
Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhanot S, Monia BP, Jirousek MR. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci U S A 2002;99:11357-62. [PMID: 12169659 PMCID: PMC123261 DOI: 10.1073/pnas.142298199] [Citation(s) in RCA: 331] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]  Open
55
Hu Q, Bally MB, Madden TD. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system. Nucleic Acids Res 2002;30:3632-41. [PMID: 12177306 PMCID: PMC137064 DOI: 10.1093/nar/gkf448] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]  Open
56
Renneberg D, Bouliong E, Reber U, Schümperli D, Leumann CJ. Antisense properties of tricyclo-DNA. Nucleic Acids Res 2002;30:2751-7. [PMID: 12087157 PMCID: PMC117067 DOI: 10.1093/nar/gkf412] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
57
Leumann CJ. DNA analogues: from supramolecular principles to biological properties. Bioorg Med Chem 2002;10:841-54. [PMID: 11836090 DOI: 10.1016/s0968-0896(01)00348-0] [Citation(s) in RCA: 204] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
58
Corey DR. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 2002;21:631-7. [PMID: 11850789 DOI: 10.1038/sj.onc.1205063] [Citation(s) in RCA: 76] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
59
Steiger MA, Decker CJ. New twists in understanding the fate of antisense oligodeoxynucleotide mRNA targets. Mol Cell 2001;8:732-3. [PMID: 11684007 DOI: 10.1016/s1097-2765(01)00370-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
60
Jayaraman A, Walton SP, Yarmush ML, Roth CM. Rational selection and quantitative evaluation of antisense oligonucleotides. BIOCHIMICA ET BIOPHYSICA ACTA 2001;1520:105-14. [PMID: 11513951 DOI: 10.1016/s0167-4781(01)00229-9] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
61
Tamm I, Dörken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet 2001;358:489-97. [PMID: 11513935 DOI: 10.1016/s0140-6736(01)05629-x] [Citation(s) in RCA: 172] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
62
Berton M, Turelli P, Trono D, Stein CA, Allémann E, Gurny R. Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles. Pharm Res 2001;18:1096-101. [PMID: 11587479 DOI: 10.1023/a:1010962507273] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
63
Ushijima K, Shirakawa M, Kagoshima K, Park WS, Miyano-Kurosaki N, Takaku H. Anti-HIV-1 activity of an antisense phosphorothioate oligonucleotide bearing imidazole and primary amine groups. Bioorg Med Chem 2001;9:2165-9. [PMID: 11504653 DOI: 10.1016/s0968-0896(01)00126-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
64
Germann MW, Aramini JM, Kalisch BW, van de Sande JH. Structural, dynamic, and enzymatic properties of mixed alpha/beta-oligonucleotides containing polarity reversals. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS 2001;20:493-9. [PMID: 11563065 DOI: 10.1081/ncn-100002324] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
65
Baker BF. The role of antisense oligonucleotides in the wave of genomic information. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS 2001;20:397-9. [PMID: 11563054 DOI: 10.1081/ncn-100002313] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
66
Vickers TA, Wyatt JR, Burckin T, Bennett CF, Freier SM. Fully modified 2' MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res 2001;29:1293-9. [PMID: 11238995 PMCID: PMC29745 DOI: 10.1093/nar/29.6.1293] [Citation(s) in RCA: 88] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
67
Baker BF, Condon TP, Koller E, McKay RA, Siwkowski AM, Vickers TA, Monia BP. Discovery and analysis of antisense oligonucleotide activity in cell culture. Methods 2001;23:191-8. [PMID: 11181038 DOI: 10.1006/meth.2000.1120] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
68
Crooke ST. Potential roles of antisense technology in cancer chemotherapy. Oncogene 2000;19:6651-9. [PMID: 11426651 DOI: 10.1038/sj.onc.1204093] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
69
Hnatowich DJ. Antisense imaging: where are we now? Cancer Biother Radiopharm 2000;15:447-57. [PMID: 11155817 DOI: 10.1089/cbr.2000.15.447] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
70
Wilds CJ, Damha MJ. 2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies. Nucleic Acids Res 2000;28:3625-35. [PMID: 10982885 PMCID: PMC110742 DOI: 10.1093/nar/28.18.3625] [Citation(s) in RCA: 135] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2000] [Revised: 07/18/2000] [Accepted: 07/18/2000] [Indexed: 11/13/2022]  Open
71
Koller E, Gaarde WA, Monia BP. Elucidating cell signaling mechanisms using antisense technology. Trends Pharmacol Sci 2000;21:142-8. [PMID: 10740290 DOI: 10.1016/s0165-6147(00)01448-6] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
72
Current Awareness on Comparative and Functional Genomics. Yeast 2000. [DOI: 10.1002/1097-0061(20000630)17:2<159::aid-yea8>3.0.co;2-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open
PrevPage 2 of 2 12Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA